Resveratrol Analog 4-Bromo-Resveratrol Inhibits Gastric Cancer Stemness through the SIRT3-c-Jun N-Terminal Kinase Signaling Pathway
Chemotherapy is the treatment of choice for gastric cancer, but the currently available therapeutic drugs have limited efficacy. Studies have suggested that gastric cancer stem cells may play a key role in drug resistance in chemotherapy. Therefore, new agents that selectively target gastric cancer...
Main Authors: | Yun-Shen Tai, Yi-Shih Ma, Chun-Lin Chen, Hsin-Yi Tsai, Chin-Chuan Tsai, Meng-Chieh Wu, Chih-Yi Chen, Ming-Wei Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Current Issues in Molecular Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/1467-3045/44/1/5 |
Similar Items
-
Resveratrol as Chemosensitizer Agent: State of Art and Future Perspectives
by: Veronica Cocetta, et al.
Published: (2021-02-01) -
Anticancer Potential of Resveratrol, β-Lapachone and Their Analogues
by: Danielly C. Ferraz da Costa, et al.
Published: (2020-02-01) -
Resveratrol overcomes TRAIL resistance in human colon cancer cells
by: Xiao-Bing Li, et al.
Published: (2015-07-01) -
Applications of resveratrol in the treatment of gastrointestinal cancer
by: Mohammad Roshani, et al.
Published: (2022-09-01) -
Resveratrol-like Compounds as SIRT1 Activators
by: Lidia Ciccone, et al.
Published: (2022-12-01)